Latest Breaking News On - Epilepsy drugs market - Page 1 : comparemela.com

Share: ResearchAndMarkets.com s offering. Global Epilepsy Drugs Market to Reach $5.8 Billion by 2027 Amid the COVID-19 crisis, the global market for Epilepsy Drugs estimated at US$ 4.6 Billion in the year 2020, is projected to reach a revised size of US$ 5.8 Billion by 2027, growing at a CAGR of 3.3% over the analysis period 2020-2027. First Generation, one of the segments analyzed in the report, is projected to record a 2.5% CAGR and reach US$ 1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Second Generation segment is readjusted to a revised 3.2% CAGR for the next 7-year period.

United statesSouth koreaSanofi aventisAbbott laboratories incCephalon incPfizer incShire plcTansna therapeutics incPharma incMarket trajectoryEpilepsy drugs marketEpilepsy drugsSecond generationWhile chinaGeneration segmentThird generation